Related references
Note: Only part of the references are listed.A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity
Fadi Jacob et al.
CELL (2020)
Medium-throughput Drug Screening of Patient-derived Organoids from Colorectal Peritoneal Metastases to Direct Personalized Therapy
Vignesh Narasimhan et al.
CLINICAL CANCER RESEARCH (2020)
Patient-derived tumor organoid predicts drugs response in glioblastoma: A step forward in personalized cancer therapy?
Herbert H-F Loong et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2020)
BRAF Inhibitors: Molecular Targeting and Immunomodulatory Actions
Ilaria Proietti et al.
CANCERS (2020)
Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology
Anna Golebiewska et al.
ACTA NEUROPATHOLOGICA (2020)
Patient-Derived Ovarian Cancer Organoids Mimic Clinical Response and Exhibit Heterogeneous Inter- and Intrapatient Drug Responses
Chris Jenske de Witte et al.
CELL REPORTS (2020)
Establishment of patient-derived cancer organoids for drug-screening applications
Else Driehuis et al.
NATURE PROTOCOLS (2020)
Generation and biobanking of patient-derived glioblastoma organoids and their application in CAR T cell testing
Fadi Jacob et al.
NATURE PROTOCOLS (2020)
Subtype-specific signaling pathways and genomic aberrations associated with prognosis of glioblastoma
Ae Kyung Park et al.
NEURO-ONCOLOGY (2019)
An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity
Oded Kopper et al.
NATURE MEDICINE (2019)
Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients
Salo N. Ooft et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening
Minsuh Kim et al.
NATURE COMMUNICATIONS (2019)
Pancreatic cancer organoids recapitulate disease and allow personalized drug screening
Else Driehuis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
Norman Sachs et al.
CELL (2018)
Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer
Suk Hyung Lee et al.
CELL (2018)
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
Georgios Vlachogiannis et al.
SCIENCE (2018)
Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived Xenografts
Benjamin J. Drapkin et al.
CANCER DISCOVERY (2018)
Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer
Herve Tiriac et al.
CANCER DISCOVERY (2018)
Glioblastoma Model Using Human Cerebral Organoids
Junko Ogawa et al.
CELL REPORTS (2018)
Estimation of the Percentage of US Patients With Cancer Who Benefit From Genome-Driven Oncology
John Marquart et al.
JAMA ONCOLOGY (2018)
A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening
Helen H. N. Yang et al.
CELL STEM CELL (2018)
Patient-derived xenografts undergo mouse-specific tumor evolution
Uri Ben-David et al.
NATURE GENETICS (2017)
CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2017)
CGCG clinical practice guidelines for the management of adult diffuse gliomas
Tao Jiang et al.
CANCER LETTERS (2016)
A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo
Christopher G. Hubert et al.
CANCER RESEARCH (2016)
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
Marc van de Wetering et al.
CELL (2015)
Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung Adenocarcinoma
Erin L. Stewart et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
Hui Gao et al.
NATURE MEDICINE (2015)
Liver-Tumor Hybrid Organoids for Modeling Tumor Growth and Drug Response In Vitro
Aleksander Skardal et al.
ANNALS OF BIOMEDICAL ENGINEERING (2015)
A Molecularly Annotated Platform of Patient-Derived Xenografts (Xenopatients) Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer
Andrea Bertotti et al.
CANCER DISCOVERY (2011)
A novel approach to the identification and enrichment of cancer stem cells from a cultured human glioma cell line
Zhi-hua Zhou et al.
CANCER LETTERS (2009)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Share Paper
